Glaukos (GKOS) EBT Margin (2014 - 2026)

Glaukos' (GKOS) quarterly EBT Margin came in at 12.82% in Q1 2026, up 389.0% year-on-year from 2.62% in Q1 2025, and up 86.88% on a QoQ basis from 97.69% in Q4 2025.

Glaukos (GKOS) EBT Margin (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of EBT Margin data on file, last reported at 12.82% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 389.0% year-over-year to 12.82% in Q1 2026; TTM through Mar 2026 was 35.28%, a 488.0% decrease from a year earlier, with the FY2025 full-year figure at 38.04%, down 7.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 12.82%, up from 97.69% in the prior quarter.
  • Over the last five years, EBT Margin for GKOS reached as high as 8.43% in Q1 2022 and fell as low as 97.69% in Q4 2025.
  • Historically, EBT Margin has averaged 36.42% across 5 years, with a median of 38.96% in 2023.
  • On a YoY basis, EBT Margin climbed as much as 3684 bps in 2025 and fell as far as 6575 bps in 2025.
  • Year by year, EBT Margin stood at 47.8% in 2022, then increased by 7 bps to 44.58% in 2023, then gained by 28 bps to 31.94% in 2024, then slumped by 206 bps to 97.69% in 2025, then jumped by 87 bps to 12.82% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 12.82% in Q1 2026, 97.69% in Q4 2025, and 11.98% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.98%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.12%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 18.70%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 27.84%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 22.61%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.84%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn -12.82%

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.82%
Dec 31, 2025 -97.69%
Sep 30, 2025 -11.98%
Jun 30, 2025 -15.64%
Mar 31, 2025 -16.71%
Dec 31, 2024 -31.94%
Sep 30, 2024 -21.96%
Jun 30, 2024 -52.48%
Mar 31, 2024 -47.26%
Dec 31, 2023 -44.58%
Sep 30, 2023 -38.96%
Jun 30, 2023 -40.27%
Mar 31, 2023 -46.31%
Dec 31, 2022 -47.80%
Sep 30, 2022 -38.35%
Jun 30, 2022 -62.79%
Mar 31, 2022 8.43%
Dec 31, 2021 -30.36%
Sep 30, 2021 8.61%
Jun 30, 2021 -22.12%